S&P Futures
5,899.25 +12.25 (+0.21%) Dow Futures
43,512.00 +1.00 (+0.00%) Nasdaq Futures
20,463.25 +95.25 (+0.47%) Russell 2000 Futures
2,297.10 -0.60 (-0.03%) Crude Oil
70.83 +0.16 (+0.23%) Gold
2,718.60 +11.10 (+0.41%)
Redcare Pharmacy NV (RDC.BE)
| Previous Close | 145.00 |
| Open | 144.80 |
| Bid | 144.20 x N/A |
| Ask | 145.30 x N/A |
| Day's Range | 144.50 - 144.90 |
| 52 Week Range | 95.95 - 152.40 |
| Volume | |
| Avg. Volume | 26 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Nov 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.3 German Growth Stocks With High Insider Ownership Growing Earnings At 54%
As the German economy faces a forecasted contraction in 2024, with factory orders experiencing a significant decline, investors are increasingly focused on identifying resilient opportunities within the market. In this context, growth companies with high insider ownership can be particularly appealing, as they often demonstrate strong alignment between management and shareholder interests and have the potential to capitalize on any economic rebound.
Simply Wall St.3 German Growth Stocks With Strong Insider Ownership
As the German economy faces a contraction in 2024, marked by plunging factory orders and a challenging economic landscape, investors are keenly observing companies that can navigate these turbulent times. In this context, growth stocks with strong insider ownership often attract attention as they may indicate confidence from those closest to the business, potentially offering resilience amid broader market challenges.
